Establishment Labs (ESTA) – Investment Analysts’ Recent Ratings Changes

A number of firms have modified their ratings and price targets on shares of Establishment Labs (NASDAQ: ESTA) recently:

• 12/22/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/17/2025 – Establishment Labs had its price target raised by analysts at Canaccord Genuity Group Inc. from $72.00 to $85.00. They now have a “buy” rating on the stock.
• 12/17/2025 – Establishment Labs had its price target raised by analysts at JPMorgan Chase & Co. from $71.00 to $80.00. They now have an “overweight” rating on the stock.
• 12/17/2025 – Establishment Labs had its price target raised by analysts at Mizuho from $85.00 to $90.00. They now have an “outperform” rating on the stock.
• 12/15/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/11/2025 – Establishment Labs had its price target raised by analysts at Citigroup Inc. from $62.00 to $75.00. They now have a “neutral” rating on the stock.
• 12/10/2025 – Establishment Labs had its price target raised by analysts at Needham & Company LLC from $70.00 to $84.00. They now have a “buy” rating on the stock.
• 12/8/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/14/2025 – Establishment Labs had its price target raised by analysts at BTIG Research from $70.00 to $81.00. They now have a “buy” rating on the stock.
• 11/13/2025 – Establishment Labs had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 11/6/2025 – Establishment Labs had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $71.00. They now have an “overweight” rating on the stock.
• 11/6/2025 – Establishment Labs had its price target raised by analysts at Canaccord Genuity Group Inc. from $60.00 to $72.00. They now have a “buy” rating on the stock.
• 11/6/2025 – Establishment Labs had its price target raised by analysts at Needham & Company LLC from $48.00 to $70.00. They now have a “buy” rating on the stock.
• 11/6/2025 – Establishment Labs had its price target raised by analysts at Mizuho from $70.00 to $85.00. They now have an “outperform” rating on the stock.
• 11/5/2025 – Establishment Labs had its price target raised by analysts at BTIG Research from $62.00 to $70.00. They now have a “buy” rating on the stock.

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.